leisure time -WSS

leisure time

author：knowledge 2025-10-02 00:30:21 - browse：52275

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How redistricting in 6 states could affect who controls Congress

WSS

Let's speed up science by embracing open access publishing

Drinking water from half of US faucets contains PFAS: Study

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

See how much Covid

Letters to First Opinion on caregivers, digital health, and more

Let's speed up science by embracing open access publishing

leisure time

leisure time

hotspot

Walensky prepares to leave CDC — and Congress — behind

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

What does generative AI mean for health care? We asked experts

Why Titanic fascinates society, still drawing tours to the wreckage

Cancer drug shortages should be causing more outrage

The PBM ad wars are taking over Washington, D.C.

23andMe had bad news about my health. I wish a person had delivered it

HIV drugs protect against transmission, even in unprotected sex

Bright Health sells Medicare Advantage business to Molina

See how much Covid

knowledge

House panel to mark up pandemic

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

The PBM ad wars are taking over Washington, D.C.

Rare Northern Lights show in US this week: Where and how to see it

The PBM ad wars are taking over Washington, D.C.

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

entertainment

leisure time

leisure time

knowledge